Ann: Phase 1 trial commences Q1, 2022 for Emyrias ultra-pure CBD, page-2

  1. 1,796 Posts.
    lightbulb Created with Sketch. 195
    I found this part really interesting, "recently completed animal studies evaluating EMD-RX5 suggest that it has improved bioavailability compared to Epidyolex". Basically you can ingest less and still have the same or greater CBD therapeutic benefit, pretty exciting stuff.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
3.5¢
Change
0.001(2.94%)
Mkt cap ! $21.40M
Open High Low Value Volume
3.4¢ 3.5¢ 3.1¢ $221.0K 6.502M

Buyers (Bids)

No. Vol. Price($)
1 400000 3.4¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 392668 1
View Market Depth
Last trade - 16.11pm 18/07/2025 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.